Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Kymera Therapeutics Inc (KYMR)

272 + Investors. Track Smart Money conviction in KYMR. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +24
Streak
3Q ▲
Buyers last Q
58%

Smart Money Signals — KYMR

Based on 282 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added KYMR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
282 hedge funds hold KYMR right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +33% more funds vs a year ago

fund count last 6Q
+70 new funds entered over the past year (+33% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 58% buying

153 buying113 selling
Last quarter: 153 funds bought or added vs 113 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+8 vs last Q)

new funds entering per quarter
Funds opening a new KYMR position: 37 → 68 → 46 → 54. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 37% long-term, 32% new

37% conviction (2yr+) 31% medium 32% new
Of the 282 current holders: 105 (37%) held >2 years, 87 held 1–2 years, and 90 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +37% but shares only +7% — price-driven

Value
+36%
Shares
+7%
Last quarter: the total dollar value of institutional holdings rose +37%, but actual share count only changed +7%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~54 new funds/quarter

64 → 37 → 68 → 46 → 54 new funds/Q
New funds entering each quarter: 37 → 68 → 46 → 54. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 49% veterans vs 39% newcomers

49% veterans 13% 1-2yr 39% new
Entry-cohort mix of 288 holders: 140 (49%) are 2+ year veterans, 37 entered 1–2 years ago, and 111 (39%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 47% AUM from top-100 funds

47% from top-100 AUM funds
58 of 275 holders are among the 100 largest funds by AUM, controlling 47% of total institutional value in KYMR. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.2
out of 10
Moderate Exit Risk
Exit risk score 4.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — KYMR

In 2026 Q2, 153 hedge funds were net buyers of KYMR (54 opened a new position, 99 added to an existing one), while 113 reduced or exited (83 trimmed, 30 sold completely) — a 58% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 47% of total institutional value in KYMR is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +24 funds (more new holders than closures). Total institutional holders: 282.

Hedge Fund Ownership: KYMR

How many hedge funds hold KYMR — quarterly history vs. share price
Quarterly hedge fund ownership of KYMR vs. share price

Market Analysis: KYMR

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: KYMR

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

12 top-rated funds 10 high-conviction
Consensus
4.8
/ 10
breadth
×
Elite
4.4
/ 10
conviction
Hedge Fund Positioning: KYMR
272 + Investors

Track Smart Money conviction in KYMR. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 272 258 5.43%
13F Shares 98M 97M 0.92%
Total Value $9.60B $7.07B 35.87%
New Positions 53 46 +7
Increased Positions 98 94 +4
Closed Positions 32 40 -8
Reduced Positions 80 72 +8
Total Calls 5 3 66.67%
Total Puts 8 4 100.0%
PUT/CALL Ratio 1.6 1.33 Bearish

Statistics: KYMR

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

272 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in KYMR. Verified SEC 13F-HR filings.

QUARTER:
Top 25 KYMR holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Atlas Venture Life Science Advisors, LLC 37.05% 2,847,541 $326.5M
2 Merck & Co., Inc. 16.82% 772,165 $88.5M
3 Bvf Inc/Il 11.35% 3,872,052 $444.0M
4 Avoro Capital Advisors LLC 7.70% 7,474,747 $857.1M
5 Siren, L.L.C. 6.81% 2,935,830 $336.7M
6 AJU IB Investment Co., Ltd. 5.36% 19,648 $1.6M
7 Baker BROS. Advisors LP 4.97% 8,657,242 $992.7M
8 Boxer Capital Management, LLC 3.71% 429,100 $49.2M
9 Octagon Capital Advisors LP 3.20% 310,000 $35.5M
10 Eagle Health Investments LP 3.16% 166,148 $19.1M
11 Boone Capital Management LLC 3.04% 113,173 $13.0M
12 Nan Fung Group Holdings Ltd 2.69% 30,875 $3.5M
13 Foresite Capital Management VI LLC 2.61% 146,332 $16.8M
14 Rock Springs Capital Management LP 2.54% 453,156 $52.0M
15 Yiheng Capital Management, L.P. 2.50% 63,440 $7.3M
16 Diadema Partners LP 2.17% 149,700 $17.2M
17 Deer Management Co. LLC 1.78% 125,895 $14.4M
18 Commodore Capital LP 1.71% 250,000 $28.7M
19 Braidwell LP 1.60% 378,163 $43.4M
20 Nextech Invest Ltd. 1.52% 278,896 $32.0M
21 First Turn Management, LLC 1.26% 102,533 $11.8M
22 Scientech Research LLC 1.20% 12,943 $1.5M
23 Patient Square Capital LP 0.84% 47,500 $5.4M
24 Frontier Capital Management Co LLC 0.79% 740,866 $85.0M
25 Atika Capital Management LLC 0.78% 104,000 $11.9M
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Kymera Therapeutics Inc (KYMR)

What does the Smart Money Trend signal show for KYMR?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added KYMR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for KYMR?

Slight buying edge — 58% buying: Last quarter: 153 funds bought or added vs 113 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for KYMR holders?

Elite ownership — 47% AUM from top-100 funds: 58 of 275 holders are among the 100 largest funds by AUM, controlling 47% of total institutional value in KYMR. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held KYMR?

Mixed — 37% long-term, 32% new: Of the 282 current holders: 105 (37%) held >2 years, 87 held 1–2 years, and 90 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →